Plexus (NASDAQ:PLXS) Cut to Hold at Zacks Research

Zacks Research downgraded shares of Plexus (NASDAQ:PLXSFree Report) from a strong-buy rating to a hold rating in a research report report published on Monday,Zacks.com reports.

PLXS has been the topic of a number of other research reports. Benchmark reaffirmed a “buy” rating and issued a $220.00 price objective on shares of Plexus in a report on Monday, March 16th. Stifel Nicolaus increased their price objective on shares of Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a report on Friday, January 30th. Wall Street Zen cut shares of Plexus from a “buy” rating to a “hold” rating in a report on Sunday, March 8th. Williams Trading set a $195.00 price objective on shares of Plexus in a report on Wednesday, January 28th. Finally, Weiss Ratings raised shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, March 6th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $194.20.

Check Out Our Latest Analysis on Plexus

Plexus Stock Down 3.3%

Shares of NASDAQ:PLXS opened at $220.49 on Monday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. Plexus has a 1-year low of $115.35 and a 1-year high of $232.17. The company’s fifty day moving average is $202.69 and its two-hundred day moving average is $171.17. The stock has a market capitalization of $5.91 billion, a price-to-earnings ratio of 34.29 and a beta of 0.75.

Plexus (NASDAQ:PLXSGet Free Report) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same quarter last year, the company earned $1.73 EPS. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Equities analysts anticipate that Plexus will post 5.9 EPS for the current year.

Insider Activity

In other Plexus news, CFO Patrick John Jermain sold 4,841 shares of the firm’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $204.01, for a total transaction of $987,612.41. Following the transaction, the chief financial officer owned 20,469 shares of the company’s stock, valued at approximately $4,175,880.69. This trade represents a 19.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Todd P. Kelsey sold 8,120 shares of the firm’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $205.65, for a total transaction of $1,669,878.00. Following the transaction, the chief executive officer directly owned 78,598 shares in the company, valued at approximately $16,163,678.70. The trade was a 9.36% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 49,495 shares of company stock worth $10,009,836 in the last 90 days. 1.78% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Plexus

Several large investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in Plexus by 0.6% during the 3rd quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company’s stock valued at $533,016,000 after buying an additional 22,374 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Plexus by 0.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company’s stock valued at $201,903,000 after purchasing an additional 7,051 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Plexus by 44.2% during the 3rd quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock valued at $159,722,000 after purchasing an additional 338,119 shares in the last quarter. State Street Corp boosted its position in shares of Plexus by 2.3% during the 2nd quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock valued at $143,361,000 after purchasing an additional 24,115 shares in the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in shares of Plexus by 4.0% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 915,296 shares of the technology company’s stock valued at $132,434,000 after purchasing an additional 35,237 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Read More

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.